Metraipolis › archive › dc_9782c19ba422

Abbott Laboratories v. Gardner — Wikipedia (en)

Source: Wikipedia (en)
Original: https://en.wikipedia.org/wiki/Abbott_Laboratories_v._Gardner
License (as archived): CC-BY-SA-4.0
Archived: 2026-11-07T05:37:08.360Z
SHA-256 of the archived text: 5b299e45b3e7bfdeb0bb7d5496cc51b7e6d89ccd99be1826a1358bf74860218a
Stable URL of this page: https://metraipolis.com/documento/dc_9782c19ba422

How to cite

Abbott Laboratories v. Gardner — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Abbott_Laboratories_v._Gardner (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_9782c19ba422 (Metraipolis archive dc_9782c19ba422, sha256 5b299e45b3e7bfdeb0bb7d5496cc51b7e6d89ccd99be1826a1358bf74860218a)

BibTeX

@misc{dc9782c19ba422,
  title = {Abbott Laboratories v. Gardner — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/Abbott_Laboratories_v._Gardner},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_9782c19ba422; sha256 5b299e45b3e7bfdeb0bb7d5496cc51b7e6d89ccd99be1826a1358bf74860218a},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Abbott_Laboratories_v._Gardner. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Abbott Laboratories v. Gardner, 387 U.S. 136 (1967), was a case heard before the United States Supreme Court. The Court held that drug companies were not prohibited by the ripeness doctrine from challenging a U.S. Food and Drug Administration (FDA) regulation requiring a prescription drug's generic name to appear on all related printed materials. The government argued that the case was not ripe because the regulation had yet to be enforced. That argument failed as the Court found the issues to be fit for judicial resolution, and that the drug companies would experience substantial hardship if denied a pre-enforcement challenge to the statute. Prosecution for non-compliance was likely, civil and criminal penalties could be imposed, and the drug companies would suffer reputational damage if required to violate the regulation before challenging it in court.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico).
Fonte: Wikipedia in inglese, voce «Abbott Laboratories v. Gardner» — https://en.wikipedia.org/wiki/Abbott_Laboratories_v._Gardner
Wikidata Q4664365: «1967 United States Supreme Court case» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q4664365
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Abbott_Laboratories_v._Gardner?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1351963099, consultata il 2026-11-07T05:34:01.650Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: e252bc74f94165329028072943611320f13e8683f299e75596a463a3704496f4